SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-058812
Filing Date
2024-05-13
Accepted
2024-05-13 17:03:16
Documents
12
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K tsbx-20240513.htm   iXBRL 8-K 42213
2 EX-99.1 tsbx-ex99_1.htm EX-99.1 79807
  Complete submission text file 0000950170-24-058812.txt   248648

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20240513.xsd EX-101.SCH 26013
15 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20240513_htm.xml XML 4923
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 24940153
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)